Clinical Trials

NCT04195633 | RECRUITING | PHASE2
60 participants

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2021-01-25
Completion:
2027-04-15
Conditions
  • Acute Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Adult Diffuse Large Cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Burkitt Lymphoma
  • Chronic Myeloid Leukemia, BCR-ABL1 Positive
  • Chronic Myelomonocytic Leukemia
  • Hodgkin Lymphoma
  • Lymphoblastic Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Mantle Cell Lymphoma
  • Mixed Phenotype Acute Leukemia
  • Myelodysplastic Syndrome
  • Prolymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Follicular Lymphoma
  • Refractory Marginal Zone Lymphoma
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT03899402 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
78 participants

Triple Therapy in T1DM

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2019-05-01
Completion:
2026-01-31
Conditions
  • Type 1 Diabetes Mellitus
Interventions
  • DRUG
No Results Yet
NCT03697577 | ACTIVE_NOT_RECRUITING
30 participants

CDK and Body Composition Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-29
Start Date:
2019-01-08
Completion:
2026-08-31
Conditions
  • Breast Cancer
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03590821 | NOT_YET_RECRUITING | EARLY_PHASE1
60 participants

Timed Aspirin Chronobiome Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2027-12-31
Completion:
2028-01-31
Conditions
  • Healthy
Interventions
  • DRUG
No Results Yet
NCT03199885 | TERMINATED | PHASE3
190 participants

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2019-04-05
Completion:
2024-04-30
Conditions
  • Metastatic Breast Adenocarcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Recurrent Breast Adenocarcinoma
  • Recurrent HER2-Positive Breast Carcinoma
  • Stage III Breast Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
NCT03157323 | ACTIVE_NOT_RECRUITING | NA
88 participants

Low GI Diet in Children and Adolescents With ALL

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2017-06-01
Completion:
2023-06-01
Conditions
  • Acute Lymphoblastic Leukemia, Pediatric
  • Obesity, Pediatric
Interventions
  • BEHAVIORAL
No Results Yet
NCT02984124 | COMPLETED | PHASE2/PHASE3
182 participants

Communication During Hospitalization About Resuscitation Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2016-12-31
Completion:
2023-03-31
Conditions
  • Severe Life-limiting COPD
  • Severe Life-limiting Heart Failure
  • Severe Life-limiting Cirrhosis
  • Severe Life-limiting Malignancy
  • Severe Functional Impairment
  • End Stage Renal Disease
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page